These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 34807755)

  • 1. A Photoactivable Natural Product with Broad Antiviral Activity against Enveloped Viruses, Including Highly Pathogenic Coronaviruses.
    Meunier T; Desmarets L; Bordage S; Bamba M; Hervouet K; Rouillé Y; François N; Decossas M; Sencio V; Trottein F; Tra Bi FH; Lambert O; Dubuisson J; Belouzard S; Sahpaz S; Séron K
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0158121. PubMed ID: 34807755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
    Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB
    Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of Pseudotyped Coronaviruses for the Screening of Entry Inhibitors: Green Tea Extract Inhibits the Entry of SARS-CoV-1, MERSCoV, and SARS-CoV-2 by Blocking Receptor-spike Interaction.
    Joseph J; Karthika T; Das VRA; Raj VS
    Curr Pharm Biotechnol; 2022; 23(8):1118-1129. PubMed ID: 34375189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent 3CLpro inhibitors effective against SARS-CoV-2 and MERS-CoV in animal models by therapeutic treatment.
    Li P; Kim Y; Dampalla CS; Nhat Nguyen H; Meyerholz DK; Johnson DK; Lovell S; Groutas WC; Perlman S; Chang K-O
    mBio; 2024 Feb; 15(2):e0287823. PubMed ID: 38126789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin.
    Millet JK; Séron K; Labitt RN; Danneels A; Palmer KE; Whittaker GR; Dubuisson J; Belouzard S
    Antiviral Res; 2016 Sep; 133():1-8. PubMed ID: 27424494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2.
    Sohrab SS; Suhail M; Kamal MA; Ahmad F; Azhar EI
    Curr Pharm Des; 2020; 26(41):5286-5292. PubMed ID: 32954998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleoside Inhibitors of Coronaviruses.
    Zenchenko AA; Drenichev MS; Mikhailov SN
    Curr Med Chem; 2021; 28(26):5284-5310. PubMed ID: 33563148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule Inhibitors.
    Park SB; Irvin P; Hu Z; Khan M; Hu X; Zeng Q; Chen C; Xu M; Leek M; Zang R; Case JB; Zheng W; Ding S; Liang TJ
    mBio; 2022 Feb; 13(1):e0323821. PubMed ID: 35012356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valinomycin as a potential antiviral agent against coronaviruses: A review.
    Zhang D; Ma Z; Chen H; Lu Y; Chen X
    Biomed J; 2020 Oct; 43(5):414-423. PubMed ID: 33012699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses.
    Huang T; Sun L; Kang D; Poongavanam V; Liu X; Zhan P; Menéndez-Arias L
    Adv Exp Med Biol; 2021; 1322():219-260. PubMed ID: 34258743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
    Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural and Nature-Derived Products Targeting Human Coronaviruses.
    Vougogiannopoulou K; Corona A; Tramontano E; Alexis MN; Skaltsounis AL
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33467029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets.
    Kratzel A; Kelly JN; V'kovski P; Portmann J; Brüggemann Y; Todt D; Ebert N; Shrestha N; Plattet P; Staab-Weijnitz CA; von Brunn A; Steinmann E; Dijkman R; Zimmer G; Pfaender S; Thiel V
    PLoS Biol; 2021 Dec; 19(12):e3001490. PubMed ID: 34962926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.
    Gordon CJ; Tchesnokov EP; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 Apr; 295(15):4773-4779. PubMed ID: 32094225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo.
    Chan JF; Oh YJ; Yuan S; Chu H; Yeung ML; Canena D; Chan CC; Poon VK; Chan CC; Zhang AJ; Cai JP; Ye ZW; Wen L; Yuen TT; Chik KK; Shuai H; Wang Y; Hou Y; Luo C; Chan WM; Qin Z; Sit KY; Au WK; Legendre M; Zhu R; Hain L; Seferovic H; Tampé R; To KK; Chan KH; Thomas DG; Klausberger M; Xu C; Moon JJ; Stadlmann J; Penninger JM; Oostenbrink C; Hinterdorfer P; Yuen KY; Markovitz DM
    Cell Rep Med; 2022 Oct; 3(10):100774. PubMed ID: 36195094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antivirals for Broader Coverage against Human Coronaviruses.
    Outteridge M; Nunn CM; Devine K; Patel B; McLean GR
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38275966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broad-spectrum antiviral activity of two structurally analogous CYP3A inhibitors against pathogenic human coronaviruses in vitro.
    Gallucci L; Bazire J; Davidson AD; Shytaj IL
    Antiviral Res; 2024 Jan; 221():105766. PubMed ID: 38042417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plants and Natural Products with Activity against Various Types of Coronaviruses: A Review with Focus on SARS-CoV-2.
    Llivisaca-Contreras SA; Naranjo-Morán J; Pino-Acosta A; Pieters L; Vanden Berghe W; Manzano P; Vargas-Pérez J; León-Tamariz F; Cevallos-Cevallos JM
    Molecules; 2021 Jul; 26(13):. PubMed ID: 34279439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Honokiol Inhibits SARS-CoV-2 Replication in Cell Culture at a Post-Entry Step.
    Salgado-Benvindo C; Leijs AA; Thaler M; Tas A; Arbiser JL; Snijder EJ; van Hemert MJ
    Microbiol Spectr; 2023 Jun; 11(3):e0327322. PubMed ID: 37212560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Products as Potential Therapeutic Agents for SARS-CoV-2: A Medicinal Chemistry Perspective.
    Aggarwal V; Bala E; Kumar P; Raizada P; Singh P; Verma PK
    Curr Top Med Chem; 2023; 23(17):1664-1698. PubMed ID: 36974409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.